1. Home
  2. TENX vs ATER Comparison

TENX vs ATER Comparison

Compare TENX & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • ATER
  • Stock Information
  • Founded
  • TENX 1967
  • ATER 2014
  • Country
  • TENX United States
  • ATER United States
  • Employees
  • TENX N/A
  • ATER N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • TENX Health Care
  • ATER Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • ATER Nasdaq
  • Market Cap
  • TENX 21.7M
  • ATER 22.8M
  • IPO Year
  • TENX N/A
  • ATER N/A
  • Fundamental
  • Price
  • TENX $6.75
  • ATER $2.06
  • Analyst Decision
  • TENX Strong Buy
  • ATER Strong Buy
  • Analyst Count
  • TENX 4
  • ATER 1
  • Target Price
  • TENX $20.67
  • ATER N/A
  • AVG Volume (30 Days)
  • TENX 53.9K
  • ATER 80.8K
  • Earning Date
  • TENX 03-27-2025
  • ATER 03-11-2025
  • Dividend Yield
  • TENX N/A
  • ATER N/A
  • EPS Growth
  • TENX N/A
  • ATER N/A
  • EPS
  • TENX N/A
  • ATER N/A
  • Revenue
  • TENX N/A
  • ATER $107,193,000.00
  • Revenue This Year
  • TENX N/A
  • ATER N/A
  • Revenue Next Year
  • TENX N/A
  • ATER $5.47
  • P/E Ratio
  • TENX N/A
  • ATER N/A
  • Revenue Growth
  • TENX N/A
  • ATER N/A
  • 52 Week Low
  • TENX $2.77
  • ATER $0.23
  • 52 Week High
  • TENX $7.89
  • ATER $3.95
  • Technical
  • Relative Strength Index (RSI)
  • TENX 51.52
  • ATER 41.40
  • Support Level
  • TENX $6.10
  • ATER $2.10
  • Resistance Level
  • TENX $7.69
  • ATER $2.31
  • Average True Range (ATR)
  • TENX 0.53
  • ATER 0.18
  • MACD
  • TENX -0.07
  • ATER -0.00
  • Stochastic Oscillator
  • TENX 44.12
  • ATER 31.25

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: